S1750 - International Drug Reference Pricing
Florida - 2024 Regular Session
Introduced byJoe Gruters
Last updated 7 months ago
1 Co-Sponsor
Providing legislative policy; requiring prescription drug manufacturer permitholders to annually report certain international price data to the Agency for Health Care Administration; providing for administrative enforcement by a specified fine and permit suspension; requiring the agency to contract with an entity to designate reference price source countries and establish the reference prices for prescription drugs based on certain criteria; requiring the agency contractor to reevaluate the designated reference prices source countries annually and revise, as needed, etc.
STATUS
Failed
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now